Magenta Therapeutics is a biotechnology company using stem cells to develop cellular therapies for immune and blood-based diseases that is headquartered in Cambridge, Massachusetts and was founded in 2016 by Jason Gardner.
On November 16, 2016 Magenta Therapeutics completed their series A funding round with $48.5 in funding from Third Rock Ventures and Atlas Ventures.
On May 2, 2017 Magenta Therapeutics completed their series B funding round with $50 million in funding from GV (lead investor), Third Rock Ventures, Partners Innovation Fund, Casidin Capital, Atlas Ventures, and Access Industries.
On April 9, 2018 Magenta Therapeutics completed their series C funding round with $52 million in funding from Casidin Capital (lead investor), The Watermill Group, Eventide Asset Management, EcoR1 Capital, Be The Match BioTherapies, and Access Industries.
Timeline
On April 9, 2018 Magenta Therapeutics completed their series C funding round with $52 million in funding from Casidin Capital (lead investor), The Watermill Group, Eventide Asset Management, EcoR1 Capital, Be The Match BioTherapies, and Access Industries.
On May 2, 2017 Magenta Therapeutics completed their series B funding round with $50 million in funding from GV (lead investor), Third Rock Ventures, Partners Innovation Fund, Casidin Capital, Atlas Ventures, and Access Industries.
On November 16, 2016 Magenta Therapeutics completed their series A funding round with $48.5 in funding from Third Rock Ventures and Atlas Ventures.
Funding rounds
People
Further reading
Documentaries, videos and podcasts
Companies
News
References
Company attributes
Categories
Related Topics
Contributors
- 1
Dawson Sewell
Writing about startups. - 2
Joseph Burns
My name is Joe Burns. I love technology, sports and writing! - 3
Henry Ogolla
Passionate about reading and writing. - 4
Jude Gomila
Founder and CEO of Golden, Entrepreneur. Investor in 200+ companies. Cantabrigian (Gonville and Caius). Interested in the Universe. - 5
Neelam Jhaveri
Techno Geek + Gamer + Fashionista + Sense of Humor = It's ME